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March 2011882 Abstractsincluded main pre-, intra- and postoperative parameters. Independent neu-
rological assessment with National Institute of Health Stroke Scale (NIHSS)
score calculation was performed before the operation and within the 30th
postoperative day.
Early (30 days) results were evaluated in terms of mortality, modifi-
cations in NIHSS values and stroke and death rates. The surveillance
program consisted of clinical and ultrasonographic examinations at 1, 6 and
12 months and yearly thereafter. Follow-up results (survival, occurrence of
ipsilateral stroke in TIA group, recurrence of stroke in stroke group) were
analysed by Kaplan–Meier curves.
Results: Among patients presenting with TIA, 28 had crescendo TIAs
and 23 had a recent TIA; In stroke group, two patients had a stroke in
evolution, eight patients had a recent major non-disabling stroke and 14
patients had a recent minor stroke.
Preoperativemean value ofNIHSS score in stroke groupwas 4.7 (SD3.2).
There were 2 perioperative (30 days) deaths, both in stroke group, in
one case due to acute respiratory failure and to fatal stroke in the other one
(preoperative NIHSS value 9, postoperative 17), with a cumulative 30-day
mortality rate of 2.7%, significantly higher in stroke group (8.3%) than in TIA
group (no death, p 0.03). No postoperative cerebral haemorrhage occurred.
In TIA group one postoperative major stroke occurred, with a 30-day
stroke and death rate of 1.9%.
In surviving patients of stroke group NIHSS value improved in 13
cases, with a mean improvement of 2 points (SD 0.9); in 8 cases the value
remained unchanged, while in the remaining case it increased from 2 to 4.
Mean postoperative NIHSS score in stroke group was 3.9 (SD 3.7), signif-
icantly reduced in comparison with preoperative value (p  0.001).
Mean duration of follow-up was 34 months (SD 28.1). No ipsilateral
stroke in patients of TIA group occurred; in stroke group a recurrent fatal
stroke at 1 postoperative month was recorded. Estimated 48-month stroke-
free survival rate TIA group was 95% and 79% in stroke group (p  0.02).
Conclusions: Urgent CEA in patients with recent/crescendo TIA
provided in our experience excellent results, with low rates of perioperative
and late stroke. In selected patients with acute stroke early surgery seems to
provide acceptable results.
Patients’ Radiation Doses During the Implantation of Stents in Ca-
rotid, Renal, Iliac, Femoral and Popliteal Arteries
Majewska N., Blaszak M.A., Juszkat R., Frankiewicz M., Makalowski M.,
Majewski W. Eur J Vasc Endovasc Surg 2011;41:372-7.
Objectives and Design: The aim of the study was to document the
radiation doses to patients during the implantation of stents in various arteries
and to discuss potential reasons for prolongation of radiological procedures.
Materials and Methods: Measurements of air kerma (Gy) and dose–
area product (Gy cm2) (DAP) were carried out simultaneously on a sample
of 345 patients, who underwent different interventional radiological proce-
dures involving angioplasty with stenting of 73 carotid (21.5%), 22 renal
(6.5%), 160 iliac (45%), 63 femoral (18.6%) and 27 popliteal (7.9%) arteries.
Results: The highest mean air kerma values for fluoroscopy and
exposure were found for renal angioplasty (340 and 420 mGy, respectively).
With regard to total DAP values, the highest were obtained for renal
(148 Gy cm2) and iliac/The Inter-Society Consensus for Management of
Peripheral Arterial Disease (TASC) II C (199 Gy cm2) stent implantation.
The lowest values were for carotid (53 Gy cm2), iliac/TASC II A
(6.3 Gy cm2) and femoral/TASC II A (53 Gy cm2) arteries. For 3.5% of the
patients, the air kerma was between 1 and 1.5 Gy and for 1.5%, it was
between 1.5 and 2 Gy.
Conclusions: In procedures performed on the arteries of the lower limbs,
a significantly higher dosewas received by patientswithTASC IIC lesions.With
regard to the number of stents implanted, the total DAP value was 50% higher
for simultaneous three-stent implantation than for one or two stents.
A Systematic Review of Free Tissue Transfer in the Management of
Non-traumatic Lower Extremity Wounds in Patients with Diabetes
Fitzgerald O’Connor E.J., Vesely M., Holt P.J., Jones K.G., Thompson
M.M., Hinchliffe R.J. Eur J Vasc Endovasc Surg 2011;41:391-9.
Objectives: Wounds of the lower limb in patients with diabetes are
frequently difficult to heal. Some wounds fail to heal despite optimal medical
and surgical care. This review examines the evidence for whether free tissue
transfer techniquesmay reduce the requirement of amputation in these patients.
Design: A systematic review.
Materials & Methods: Pubmed, Embase, AMED, SCOPUS and
CINAHL and Cochrane Library were searched for all articles on free tissue
transfer in lower limb wounds in patients with diabetes (September 2010).
Current experience, indications and outcomes were analysed.Readers can access EJVES articles at http://intl.eurgery. 63% of flaps were muscle based, 35% fasciocutaneous and 1.7%
mental. Pooled in-hospital mortality rate was 4.4%, flap survival was 92%
nd limb salvage rate of 83.4% over a 28 months average follow-up time.
Conclusions: In conclusion free tissue transfer achieves successful
ound healing in selected patients with diabetes and difficult to heal wounds
hat would have required amputation. Pre-operative optimisation of vascular
upply and eradication of infection is key to success. Objective wound
ssessment scores and a clear multidisciplinary team (MDT) approach would
mprove patient care.
oes Puncture Site Affect the Rate of Nerve Injuries Following En-
ovenous Laser Ablation of the Small Saphenous Veins?
oganci S., Yildirim V., Demirkilic U. Eur J Vasc Endovasc Surg 2011;41:
00-5.
Objectives: The small saphenous vein (SSV) lies in close relationship
ith sural nerve and is at risk of damage during surgery or vein ablation
rocedures on this vein. The aim of this study was to compare the effect of
uncture site for SSV endovenous laser ablation (EVLA) on the rate of
ost-operative sural nerve injury.
Design: Randomised controlled study.
Patients andMethods: Sixty patients with isolated SSV varicose veins (68
imbs) were randomised into two groups. All patients were treated with en-
ovenous laser ablation procedures using radial fibres and a 1470 nm diode
aser. InGroup 1, SSVswere canulated from lateralmalleolar part of the SSV. In
roup 2, SSVs were canulated in the mid-calf. EVLA procedures were per-
ormed by using 12 Wenergy and 70 J cm1 LEED (linear endovenous energy
ensity). Local pain, ecchymosis, induration and paraesthesia in treated regions,
ein diameter, treated vein length, tumescent anaesthesia volume, delivered
nergywere recorded. Follow-up visitswere arrangedon the 2ndpost-operative
ay, 7th day, 1st, 2nd, 3rd and 6th months.
Results: The mean SSV diameters at sapheno-popliteal junction (SPJ)
nd calf levels were Group 1 SPJ: 6.6 S.D. 1.2 mm, Calf: 5.1 S.D. 1.1 mm,
nd Group 2 SPJ: 6.8 S.D. 1.6 mm, Calf: 4.9 S.D. 1.3 mm. Adverse events
fter treatment were 1 patient with induration, 3 with ecchymosis and 6
inimal paraesthesia in Group 1 (malleolar) and 1 local pain, 4 minimal
cchymosis or induration and 1 paraesthesia in Group 2 (mid-calf). InGroup
in two patients the paraesthesia lasted 2 months and then resolved
pontaneously. In the remaining four patients’ paraesthesia resolved in less
han 1 month without treatment. In Group 2 paraesthesia resolved sponta-
eously in two weeks. Induration, ecchymosis and local pain also resolved in
ess than 2 weeks in both groups. There was no recanalisation or reflux in the
reated SSV of either group during the follow-up period.
Conclusion: Treatment of the SSV by endovenous laser ablation using
1470 nm laser and a radial fibre is safe and effective. Puncturing the vein at
id-calf level causes less post-operative nerve injury without affecting the
ecanalisation rates.
-cell-pre-stimulatedMonocytes Promote Neovascularisation in aMu-
ine Hind Limb Ischaemia Model
ellingman A.A., Zwaginga J.J., van Beem R.T., TeRM/Smart Mix Con-
ortium, Hamming J.F., Fibbe W.E., Quax P.H.A., Geutskens S.B. Eur J
asc Endovasc Surg 2011;41:418-28.
Aim:Monocytes play a significant role in neovascularisation. The stimuli
hat differentiate monocytes along a pro-angio-/arteriogenic-supporting path-
ay are currently unclear. We investigated whether pre-stimulation of human
onocytes with soluble T-cell-derived factors improves revascularisation in
urine hind limb ischaemia as a new option for therapeutic angio- and arterio-
enesis.
Design: Human monocytes were cultured with or without soluble
-cell-derived factors. Unstimulated and pre-stimulated monocytes were
ransfused after induction of hind limb ischaemia in nude mice.
Methods: Blood flow was measured with laser Doppler perfusion
maging. Collaterals were visualised by immunohistochemistry and angiog-
aphy. Monocytes were characterised by flowcytometry and Bio-Plex assays.
Results: Transfusion of T-cell-pre-stimulated monocytes significantly
mproved blood flow recovery after hind limb ischaemia and increased
ollateral size and collateral and capillary number in the post-ischaemic paw.
re-stimulated monocytes produced a wide variety of factors that support
eovascularisation such as platelet-derived growth factor-BB, vascular-en-
othelial growth factor, interleukin-4 and tumour necrosis factor-. Few
ransfused human cells were detected in the muscle tissue, suggesting that
aracrine rather than direct effects appear responsible for the enhanced
ecovery of blood flow observed.
Conclusion:These results show a beneficial role for T-cell-pre-stimulated
onocytes in neovascularisation, rendering the monocyte a potential candidateResults: 528 patients from 18 studies were included in the systematic
review. 66% of patients had concomitant revascularisation with bypass
for regenerative cell therapy that promotes revascularisation in peripheral arterial
disease patients.lsevierhealth.com/journals/ejvs/default.cfm
